Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Berzelii Pharma AB
AB
Active
Org 5594833427
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2024
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Berzelii Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
HM
Hans Marcus Bosson
Chief Executive Officer
Chief Executive Officer
2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
BL
Bo Lars Christer Ziedén
Board of Directors
2025
HH
Hans Henrik von Celsing
Chairman
2025
CJ
Carl Johan Flodin
Board of Directors
2025
Former (1)
NR
Nicklas Richard Wall
Board of Directors
2024 – 2025
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Berzelii Pharma AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
